Skip to content

Multi Dimensional System for Evaluating a Preventive Program for Upper Extremity Disorders Among Computer Operators

Multi Dimensional System for Evaluating a Preventive Program for Upper Extremity Disorders Among Computer Operators

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01562418
Enrollment
108
Registered
2012-03-23
Start date
2009-09-30
Completion date
2013-02-28
Last updated
2012-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Disorders, Upper Extremity Pain Chronic

Keywords

Ergonomics, musculoskeletal symptoms, kinematics

Brief summary

Computer settings points to a number of risk factors which may induce the development of Work related MSD (WRMSD). In light of the expanded use of computers and the increased occurrence of Upper Extremity (UE) WRMSD among computer operators various intervention programs have been developed and tested. Nevertheless, many of these programs do not meet the criteria of quality and level of evidence. The main objective of this study is to use simultaneously a three dimensional (3D) kinematic analysis system, surface electromyography (SEMG) and fingertip force measurement system (Flexiforce) while typing, to test the efficacy of primary and secondary preventive intervention programs aimed at reducing MSD among computer operators. Work hypothesis: Significant score differences will be found on the evaluation parameters between the research group which underwent ergonomic training with biofeedback, the group without feedback, and the control group.The evaluated parameters will correlate with the appearance of MSD symptoms and pain and will affect level of function. The study will include 66 participants, programmers and computer engineers. The participants will be assigned randomly to one of three groups: 1) participants will receive ergonomic training with biofeedback; 2) participants will receive ergonomic training without biofeedback; and 3) control group, without intervention. Each group will consist of 22 participants. Treatment efficacy will be tested both at work and in the motion lab. In the lab, 3D kinematic measurements and fingertip forces relevant to typing while entering a standard text will be measured. At the work site, anthropometric and measurements, work station measurements, posture observation and questionnaires about, psychosocial status, function and pain level will be filled The preventive program will be performed at the workstation after the preliminary data collection phase. The program will consist of one group meeting at the workplace for all employees participating in the study, and individual instruction at the workstation, including 3-6 meetings for the two research groups. Data will be collected before and after the intervention program.

Interventions

Ergonomic intervention, how to sit and work, an d muscle re education with a SurfaceElrctromyograph Biofeedback (SEMG biofeedback)

BEHAVIORALStandard ergonomic intervention

Standard ergonomic intervention , how to sit and work with computers

BEHAVIORALcontrol group

general instructions no intervention

Sponsors

Medical Corps, Israel Defense Force
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* subjects working more than four hours per day in front of a computer and are right-hand dominant. * Healthy or suffering from diagnoses of UE-MSD. (e.g. Rotator cuff syndrome , Lateral epicondylitis, Cubital tunnel syndrome, Carpal tunnel syndrome, Flexor-extensor peri-tendinitis or teno-synovitis of the forearm-wrist region, De Quervain's disease and Nonspecific MSD

Exclusion criteria

* Participants suffering from orthopedic injury or neurological deficit (with the exception of the diagnosis mentioned above). * Medical conditions that cause swelling of the joints or hand numbness (pregnancy, diabetes, heart condition, arthritis).

Design outcomes

Primary

MeasureTime frameDescription
Musculoskeletal disorders measurement (MSD score)Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one.The MSD score of the whole body will be collected out of a self administrated questionnaire in the first meeting before intervention and in the last meeting. the score indicates the number of painful body regions that were harmful in the last week before answering the Questionnaire. Negative differences between post and pre intervention will indicate improvement in pain.

Secondary

MeasureTime frameDescription
Rapid Upper Limb Assessment (RULA)scoreMinimum 10 weeks and maximum 15 weeks between the first measurement and the last oneThe RULA is an observation that assess the posture at work. The assessment will be held in the work place in the first meeting before intervention and in the last meeting. The score ranged between 0-7, higher score indicates higher risk for MSD. Negative differences between post and pre intervention will indicate improvement in posture at work.
Kinematic Data [range of motion ( R.O.M) and angular velocity]measured by 3D motion analysis system.Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one.The Kinematics of the upper extremity (fingers, wrist and elbow) will be measured in the second and in the last meeting at the motion laboratory. The second meeting will be not more than 2 weeks after the first meeting.R.O.M will be measured in degrees and the angular velocity will be presented in degrees per seconds. .Negative differences between post and pre intervention indicates improvement in R.O.M and angular velocity.
Muscle activityMinimum 10 weeks and maximum 15 weeks between the first measurement and the last one.The muscle activity amplitude of the wrist and finger extensors and the upper trapezius will be measured and collected in the second meeting at the motion laboratory simultaneously with the kinematic data.The muscle amplitude will be presented as percentile of the Maximal Voluntary Contraction (MVC) of the same muscles. Higher percentage of muscle activity will indicate higher muscle load. Negative differences between post and pre intervention indicates improvement in muscle activity.
Psychosocial job characteristics assessment (DCSQ)Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one.The D.C.S.Q will be measured by a self administrated questionnaire in the first meeting before intervention and in the last meeting. The job demands score range between 5-25 and the decision latitude score range between 8-40. Low level of job demands and high decision latitude indicates low level of stress at work.

Countries

Israel

Contacts

Primary ContactYafi Levanon, MSc
yafil@post.tau.ac.il++972-52-6666598

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026